Brainomix, a health software company, and drug developer Boehringer Ingelheim will advance testing of an artificial intelligence (AI)-based tool that may enable earlier diagnosis of progressive pulmonary fibrosis (PF). The two companies are collaborating to run studies of the Brainomix 360 e-Lung, a U.S. Food…
Discussion
Note: This column describes the author’s own experiences with Ozempic (semaglutide). Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. As a person diagnosed with idiopathic pulmonary fibrosis (IPF) who received a bilateral lung transplant in July 2021,…
Insilico Medicine will soon launch an early clinical trial in China to test an inhaled version of its therapy candidate rentosertib in healthy volunteers and people with idiopathic pulmonary fibrosis (IPF). This announcement follows the clearance of the company’s investigational new drug (IND) application by the Chinese Center for…
Becoming educated and informed about PF is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your PF journey.
There is no cure for PF yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
